Your 2026 TEAM performance will determine your financial risk for the next four years.

Estimate My Hospital’s TEAM Exposure

CMS's mandatory bundled payment model is now live. 

What your hospital does in 2026 sets the reinbursement baseline CMS uses when penalties begin in 2027.

NOW

2026

Upside only. No penalties.

Your benchmark is being set right now

RISK BEGINS

2027

Two sided risk starts

Your 2026 performance determines your target price

ACTIVE PENALTIES

2027-2030

Penalties and bonuses calculated against your locked baseline

Estimate Your 2026 TEAM Opportunity

Based on your episode volume, readmission rate, and hospital size. Takes under 60 seconds.

Estimated Annual TEAM Episodes Total surgical episodes across all 5 TEAM categories (LEJR, Bowel, CABG, Hip Fracture, Spinal Fusion) Please enter a valid number.

Current 30-Day Readmission Rate Your hospital's reported 30-day readmission rate. Used as the primary cost driver in this estimate. Please enter a rate between 0.1 and 100.

Hospital Size Used to benchmark against peer hospitals

Average Cost Per Readmission (optional) Fully loaded cost estimate. Defaults to $22,000 (industry standard) if left blank.

YOUR ESTIMATED TEAM IMPACT

Episode Spend Under CMS Review

—

Year 1 Opportunity (Upside Only)

Future Risk (Year 2+)

Avoidable TEAM Cost Exposure*

—

Estimated preventable TEAM expense

Avoidable Readmissions

—

Estimated preventable readmissions per year

* Assumes 35% reduction in 30-day readmissions through combined pre-op preparation and post-discharge engagement.

What this means for your hospital:

Your current performance puts you at potential financial risk once TEAM penalties begin in 2027.

Improving in 2026 raises your CMS reimbursement baseline for the following four years.

Most mandatory TEAM hospitals are underestimating how much 2026 performance will cost or earn them over the full program.

Why 2026 matters:

It sets your CMS target price for the full 2027-2030 risk period.

It locks in your performance baseline before potential penalties apply.

It is the only window to build operational infrastructure before downside risk begins.

These estimates are based on your reported episode volume, readmission rate, and readmission cost, as well as industry-standard overall episode cost estimate based on type of facility. Actual TEAM reconciliation will vary based on CMS target pricing for your market. Participants in Performance Year 1 are not subject to downside reconciliation risk. Year 1 performance does, however, establish the CMS target price baseline used when two-sided risk begins. Caregentic 35% readmission reduction based on previous platform deployment estimates. This calculator is intended to prompt a more detailed conversation - not replace one.